Enolase isozymes in differentiated and undifferentiated medullary thyroid carcinomas
โ Scribed by Ralph Oskam; Gert Rijksen; Cees J. M. Lips; Gerard E. J. Staal
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 826 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Neuroendocrine or argyrophil cell carinoma of the cervix has recently been accepted as a distinct clinical-pathological entity. The histologic pattern of these carcinomas is usually poorly differentiated or undifferentiated. Twenty patients with a histologic diagnosis of small cell carcinoma, undiff
## Abstract Medullary thyroid carcinoma (MTC) is a rare malignancy arising from the parafollicular C cells within the thyroid gland. The majority of cases are sporadic, but at least 30% are hereditary in nature. Inherited forms of MTC occur as familial MTC or as a manifestation of multiple endocrin
The role of the TP53 gene in the development of inherited and sporadic pheochromocytomas and medullary thyroid carcinomas (MTC) has not been clarified because of conflicting reports and limitations in the assays used to detect mutations. To determine the frequency of TP53 alterations in these tumors
## BACKGROUND. Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor derived from parafollicular cells. At present, surgery is the most important treatment for MTC. ## METHODS. We describe the current approaches of MTC treatment (surgery, chemotherapy, radiation therapy, and biologic ther